Atrial fibrillation (AF) is a common condition with a global estimated prevalence of 60 million
cases, and the most common cardiac complication of hyperthyroidism, occurring in 5–15 …

Background Existing data on the risk of ischemic stroke in hyperthyroidism‐related atrial
fibrillation (AF) and the impact of long‐term anticoagulation in these patients, particularly …

Subclinical thyroid disorders have a high prevalence among older individuals and women.
Subclinical hypothyroidism is diagnosed by elevated serum levels of thyroid-stimulating …

Background We aimed to evaluate the long-term risk of ischemic stroke/systemic embolism
of hyperthyroidism-related AF. Methods This retrospective population-based cohort study …

Background: Patients with hyperthyroidism have higher risk of atrial fibrillation (AF).
However, the risk of thromboembolic event in patients with hyperthyroidism-related AF is …

Abstract Background Atrial fibrillation (Afib) is a common cardiac manifestation of
hyperthyroidism. The data regarding outcomes of Afib with and without hyperthyroidism are …

Atrial fibrillation is the most common arrhythmia worldwide with increasing frequency noted
with age. Hyperthyroidism is a well-known cause of atrial fibrillation with a 16%–60 …

Atrial fibrillation is often induced in patients with hyperthyroidism and may trigger heart
failure. Its prevalence and outcome were examined to obtain up-to-date information …

Background: Evidence on the efficacy and safety of anticoagulation in preventing stroke and
thromboembolic events in people with thyrotoxic atrial fibrillation is scarce. Objective: We …

Atrial fibrillation (AF), the most widespread arrhythmia, is a source of disability and death in
the elderly, in particular because of the functional heart failure entailed and the considerable …